News brief
On September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- encoded.com ↗Published Sep 9, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月9日，据Encoded Therapeutics官网，神经疾病基因疗法公司正式完成2.75亿美元F轮融资，由GV及另一家未具名医疗健康基金共同领投，ARCH、Braidwell、Illumina Ventures、SoftBank Vision Fund 2等参与。公司由Kartik Ramamoorthi和Stephanie Tagliatela共同创立。